Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

HomeLight

HomeLight Raises $109M in Series D

130 Lytton Avenue, Palo Alto, CA 94301March 9, 20242 min read
Employees
600+

HomeLight Raises $109M in Series D


HomeLight has successfully raised $109M in a Series D at a $1.5B valuation led by Zeev Ventures, Crosslink Capital, Group 11, Citi Ventures, Menlo Ventures, Montage Ventures.


Company Overview


HomeLight is a PropTech company headquartered in 130 Lytton Avenue, Palo Alto, CA 94301, founded in 2012 with 600+ employees.


Real estate technology platform


Fundraising Details


  • Amount Raised: $109M
  • Round Type: Series D
  • Valuation: $1.5B
  • Date: 2024-03-09
  • Investors: Zeev Ventures, Crosslink Capital, Group 11, Citi Ventures, Menlo Ventures, Montage Ventures

About HomeLight


Real estate technology platform The company is positioned in the PropTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 130 Lytton Avenue, Palo Alto, CA 94301
  • Founded: 2012
  • Team Size: 600+
  • Industry: PropTech

What This Means


This funding round demonstrates strong investor confidence in HomeLight's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The PropTech sector continues to attract significant investment as companies innovate to meet evolving market demands. HomeLight's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.5B valuation marks an important milestone for HomeLight, positioning the company among notable players in the PropTech industry.


Looking Ahead


With this new capital, HomeLight is well-positioned to execute on its growth strategy and continue building innovative solutions in the PropTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-03-09. For more information about HomeLight, visit their headquarters at 130 Lytton Avenue, Palo Alto, CA 94301.

Company Info

Headquarters
130 Lytton Avenue, Palo Alto, CA 94301
Founded
2012
Team Size
600+

Topics

Fundraising(2912)PropTech(429)Series D(267)HomeLight

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free